PRTN3 and rheumatoid arthritis: Meanwhile, a recent meta‐analysis revealed that the risk of RA‐ILD was significantly linked with the serum ACPA titer and the risk increased in ACPA‐positive patients when compared with ACPA‐negative individuals.